Catalyst Wire Dossier Catalyst Wire Dossier

Isentress

Raltegravir · Merck & Co.
Drug timelines are a Plus or Pro feature.

137 regulatory and trial events tracked for Isentress, covering 2007-10-12 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Renal Transplantation and Raltegravir in HIV-Infected Patients [Phase 3]

See pricing